Current Report Filing (8-k)
August 08 2022 - 04:22PM
Edgar (US Regulatory)
0001822359 false 0001822359 2022-08-08
2022-08-08 0001822359 DCGO:CommonStockParValue0.0001PerShareMember
2022-08-08 2022-08-08 0001822359
DCGO:WarrantsEachExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember
2022-08-08 2022-08-08 iso4217:USD xbrli:shares iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
August 8, 2022
DOCGO INC.
(Exact name of registrant as specified in its charter)
Delaware |
|
001-39618 |
|
85-2515483 |
(State
or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS
Employer
Identification No.) |
35
West 35th Street,
Floor 6,
New York,
New York |
|
10001
|
(Address of principal executive offices) |
|
(Zip
Code) |
(844)
443-6246
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last
report)
Check the appropriate box below if the Form 8-K is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
|
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425) |
|
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12) |
|
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b)) |
|
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
Common stock, par value $0.0001 per share |
|
DCGO |
|
The
Nasdaq Stock Market LLC |
Warrants, each exercisable for one share of common stock at an
exercise price of $11.50 per share |
|
DCGOW |
|
The
Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☒
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item
2.02 Results of Operations and Financial Condition
On August 8, 2022, DocGo Inc. (the “Company”) issued a press
release that announced earnings results for the quarter ended June
30, 2022. This press release is furnished as Exhibit 99.1 to this
report.
The information in Item 2.02 of this report and the exhibit
attached hereto is being furnished and shall not be deemed “filed”
for purposes of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”), nor shall it be deemed incorporated by
reference into any registration statement or other filing under the
Securities Act of 1933, as amended, or the Exchange Act, except as
shall be expressly set forth by specific reference to such
filing.
Item 9.01
Financial Statements and Exhibits
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
|
DOCGO INC. |
|
|
|
|
By: |
/s/
Andre Oberholzer |
|
|
Name:
Andre Oberholzer |
|
|
Title:
Chief Financial Officer |
Date: August 8, 2022
2
DocGo (NASDAQ:DCGO)
Historical Stock Chart
From Aug 2023 to Sep 2023
DocGo (NASDAQ:DCGO)
Historical Stock Chart
From Sep 2022 to Sep 2023